Brief: Egetis Therapeutics Q1 Loss Widens To SEK 75.0 Mln
May 3 (Reuters) - Egetis Therapeutics AB (publ)
EGTX.ST :
* Q1 REVENUE MSEK 12.1 (6.8)
* Q1 LOSS MSEK -75.0 (-74.9)
Source text for Eikon: ID:nMFN3ggth8
Further company coverage: EGTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1